Literature DB >> 9467538

Evidence of high circulating testosterone in women with prior preeclampsia.

H Laivuori1, R Kaaja, E M Rutanen, L Viinikka, O Ylikorkala.   

Abstract

Women with prior preeclampsia are characterized by hyperinsulinemia and a 2- to 3-fold excess risk of hypertension and ischemic heart disease in later life. We therefore studied whether these women present changes in pituitary, ovarian, and endothelial factors that could also affect the risk of vascular disorders. Twenty-two women with prior preeclampsia and 22 control women matched by age and body mass index were studied an average of 17 yr after delivery. Women with prior preeclampsia had elevated serum free testosterone levels (20.6 +/- 2.2 vs. 15.0 +/- 1.3 pmol/L, mean +/- SE, P = 0.03), an elevated free androgen index (3.2 +/- 0.5 vs. 1.9 +/- 0.2, P = 0.04), and an elevated free testosterone estradiol ratio (0.089 +/- 0.017 vs. 0.046 +/- 0.006, P = 0.02). The levels of insulin-like growth factor binding protein-1 decreased as expected during a 3-h oral glucose tolerance test without differences between the groups. Levels of FSH, LH, androstenedione, dehydroepiandrosterone sulfate, and endothelin-1, as well as urinary output of prostacyclin and thromboxane A2 metabolites, showed no difference between study groups. A history of preeclampsia an average of 17 yr earlier thus appears to be associated with elevated levels of testosterone, which may contribute to the increased risk of vascular morbidity in such women.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467538     DOI: 10.1210/jcem.83.2.4543

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

2.  Sexual dimorphism in activation of placental autophagy in obese women with evidence for fetal programming from a placenta-specific mouse model.

Authors:  Sribalasubashini Muralimanoharan; Xiaoli Gao; Susan Weintraub; Leslie Myatt; Alina Maloyan
Journal:  Autophagy       Date:  2016-05-03       Impact factor: 16.016

3.  Preeclampsia and androgen receptor gene CAG repeat length: results from both children and women.

Authors:  Tanja Saarela; Jarmo Jääskeläinen; Sirpa Tenhola; Raimo Voutilainen; Seppo Heinonen
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

4.  Fetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia.

Authors:  K Sathishkumar; M Balakrishnan; V Chinnathambi; M Chauhan; G D V Hankins; C Yallampalli
Journal:  J Perinatol       Date:  2011-09-08       Impact factor: 2.521

Review 5.  Progestogens with antiandrogenic properties.

Authors:  Daniel Raudrant; Thomas Rabe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Elevated serum concentrations of androgens in women with pregnancy-induced hypertension.

Authors:  Stefan Jirecek; Elmar A Joura; Clemens Tempfer; Martin Knöfler; Peter Husslein; Harald Zeisler
Journal:  Wien Klin Wochenschr       Date:  2003-03-31       Impact factor: 1.704

7.  Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport.

Authors:  Kunju Sathishkumar; Rebekah Elkins; Vijayakumar Chinnathambi; Haijun Gao; Gary D V Hankins; Chandra Yallampalli
Journal:  Reprod Biol Endocrinol       Date:  2011-08-03       Impact factor: 5.211

8.  Maternal Preeclampsia and Androgens in the Offspring around Puberty: A Follow-Up Study.

Authors:  Ingvild V Alsnes; Imre Janszky; Bjørn O Åsvold; Inger Økland; Michele R Forman; Lars J Vatten
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

Review 9.  Androgens in maternal vascular and placental function: implications for preeclampsia pathogenesis

Authors:  Sathish Kumar; Geoffrey H Gordon; David H Abbott; Jay S Mishra
Journal:  Reproduction       Date:  2018-10-16       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.